Osteoarthritis (OA) is the most common type of arthritis and a significant cause of disability worldwide. With an aging population in Canada, the prevalence and burden of OA is expected to increase. Knee OA is the most common form of OA, comprising upwards of 30% of cases. Early-stage OA can be difficult to diagnose, as often times pain and radiographical evidence do not align; however, abnormal subchondral bone remodelling has been considered to have an important role in OA pathogenesis, and some propose that it could offer a target for OA treatment. Clinically, measures of bone remodelling have been performed on iliac crest bone biopsies that are invasive and do not capture local changes. Recently, high resolution peripheral quantitative computed tomography (HR-pQCT) has been utilized in several different ways to analyse bone dynamics, or how the bone changes over time. These measurements are sensitive to several factors such as noise and motion but have yet to be validated in humans. The purpose of this study was to determine whether HR-pQCT can be used to measure longitudinal bone remodelling at the knee in humans with knee OA. Longitudinal bone remodelling results were compared to same-day rescan images to conduct a repeatability analysis. There were no significant differences between longitudinal and rescan results for bone formation (p = 0.47), bone resorption (p = 0.12), or net bone remodelling (p = 0.748). Additionally, the least detectable changes measured were 10.88% for bone formation, 10.53% for bone resorption, and 4.05% for net bone remodelling. These results indicate that with the current imaging procedures, there is too much error in the scans and processing pipeline to measure bone remodelling longitudinally in-vivo in the knee.